NasdaqCM - Nasdaq Real Time Price USD

Ekso Bionics Holdings, Inc. (EKSO)

1.2000 -0.0800 (-6.25%)
As of 12:09 PM EDT. Market Open.
Loading Chart for EKSO
DELL
  • Previous Close 1.2800
  • Open 1.2700
  • Bid 1.1500 x 100
  • Ask 1.2800 x 100
  • Day's Range 1.1701 - 1.2900
  • 52 Week Range 0.6200 - 3.1290
  • Volume 27,258
  • Avg. Volume 167,743
  • Market Cap (intraday) 21.484M
  • Beta (5Y Monthly) 1.64
  • PE Ratio (TTM) --
  • EPS (TTM) -1.1000
  • Earnings Date Apr 29, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 9.25

Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. The company provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; Ekso Indego Therapy, an adjustable and lower-limb powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; Ekso Nomad, a power knee ankle foot orthosis; and Ekso EV, a wearable upper body exoskeleton that elevates and supports a worker's arms to assist with tasks from chest height to overhead. Ekso Bionics Holdings, Inc. was founded in 2005 and is headquartered in San Rafael, California.

www.eksobionics.com

70

Full Time Employees

December 31

Fiscal Year Ends

Recent News: EKSO

Performance Overview: EKSO

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

EKSO
52.00%
S&P 500
6.97%

1-Year Return

EKSO
23.08%
S&P 500
25.32%

3-Year Return

EKSO
78.95%
S&P 500
22.06%

5-Year Return

EKSO
96.54%
S&P 500
74.37%

Compare To: EKSO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: EKSO

Valuation Measures

Annual
As of 4/25/2024
  • Market Cap

    22.92M

  • Enterprise Value

    21.45M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.97

  • Price/Book (mrq)

    1.82

  • Enterprise Value/Revenue

    1.17

  • Enterprise Value/EBITDA

    -1.62

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -83.14%

  • Return on Assets (ttm)

    -27.06%

  • Return on Equity (ttm)

    -79.89%

  • Revenue (ttm)

    18.28M

  • Net Income Avi to Common (ttm)

    -15.2M

  • Diluted EPS (ttm)

    -1.1000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    8.64M

  • Total Debt/Equity (mrq)

    56.86%

  • Levered Free Cash Flow (ttm)

    -6.96M

Research Analysis: EKSO

Analyst Price Targets

9.25
9.25 Average
1.2000 Current
9.25 High
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Company Insights: EKSO

Fair Value

1.2000 Current
 

Dividend Score

0 Low
EKSO
Sector Avg.
100 High
 

Hiring Score

0 Low
EKSO
Sector Avg.
100 High
 

Insider Sentiment Score

0 Low
EKSO
Sector Avg.
100 High
 

People Also Watch